These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 38088003)

  • 1. Prescription opioid use among people with opioid dependence and concurrent benzodiazepine and gabapentinoid exposure: An analysis of overdose and all-cause mortality.
    Bharat C; Gisev N; Barbieri S; Dobbins T; Larney S; Buizen L; Degenhardt L
    Int J Drug Policy; 2024 Jan; 123():104287. PubMed ID: 38088003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prescription of benzodiazepines, z-drugs, and gabapentinoids and mortality risk in people receiving opioid agonist treatment: Observational study based on the UK Clinical Practice Research Datalink and Office for National Statistics death records.
    Macleod J; Steer C; Tilling K; Cornish R; Marsden J; Millar T; Strang J; Hickman M
    PLoS Med; 2019 Nov; 16(11):e1002965. PubMed ID: 31770388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-fatal overdose risk associated with prescribing opioid agonists concurrently with other medication: Cohort study conducted using linked primary care, secondary care and mortality records.
    Domzaridou E; Carr MJ; Millar T; Webb RT; Ashcroft DM
    Addiction; 2023 Dec; 118(12):2374-2383. PubMed ID: 37536685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trends in opioid analgesic utilisation among people with a history of opioid dependence.
    Bharat C; Gisev N; Barbieri S; Dobbins T; Larney S; Farrell M; Degenhardt L
    Drug Alcohol Depend; 2022 Sep; 238():109548. PubMed ID: 35841733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does opioid agonist treatment reduce overdose mortality risk in people who are older or have physical comorbidities? Cohort study using linked administrative health data in New South Wales, Australia, 2002-17.
    Larney S; Jones NR; Hickman M; Nielsen S; Ali R; Degenhardt L
    Addiction; 2023 Aug; 118(8):1527-1539. PubMed ID: 36843415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Associations between prescribed benzodiazepines, overdose death and buprenorphine discontinuation among people receiving buprenorphine.
    Park TW; Larochelle MR; Saitz R; Wang N; Bernson D; Walley AY
    Addiction; 2020 May; 115(5):924-932. PubMed ID: 31916306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dosing profiles of concurrent opioid and benzodiazepine use associated with overdose risk among US Medicare beneficiaries: group-based multi-trajectory models.
    Lo-Ciganic WH; Hincapie-Castillo J; Wang T; Ge Y; Jones BL; Huang JL; Chang CY; Wilson DL; Lee JK; Reisfield GM; Kwoh CK; Delcher C; Nguyen KA; Zhou L; Shorr RI; Guo J; Marcum ZA; Harle CA; Park H; Winterstein A; Yang S; Huang PL; Adkins L; Gellad WF
    Addiction; 2022 Jul; 117(7):1982-1997. PubMed ID: 35224799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dispensations of benzodiazepines, z-hypnotics, and gabapentinoids to patients receiving opioid agonist therapy; a prospective cohort study in Norway from 2013 to 2017.
    Vold JH; Skurtveit S; Aas C; Chalabianloo F; Kloster PS; Johansson KA; Fadnes LT
    BMC Health Serv Res; 2020 Apr; 20(1):352. PubMed ID: 32334602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concurrent prescriptions for opioids and benzodiazepines and risk of opioid overdose: protocol for a retrospective cohort study using linked administrative data.
    Liu EY; Tamblyn R; Filion KB; Buckeridge DL
    BMJ Open; 2021 Feb; 11(2):e042299. PubMed ID: 33602708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cohort Study of the Impact of High-Dose Opioid Analgesics on Overdose Mortality.
    Dasgupta N; Funk MJ; Proescholdbell S; Hirsch A; Ribisl KM; Marshall S
    Pain Med; 2016 Jan; 17(1):85-98. PubMed ID: 26333030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of 30-day prescribed opioid dose trajectory on fatal overdose risk: A population-based, statewide cohort study.
    Henry SG; Fang SY; Crawford AJ; Wintemute GJ; Tseregounis IE; Gasper JJ; Shev A; Cartus AR; Marshall BDL; Tancredi DJ; Cerdá M; Stewart SL
    J Gen Intern Med; 2024 Feb; 39(3):393-402. PubMed ID: 37794260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Benzodiazepine prescribing patterns and deaths from drug overdose among US veterans receiving opioid analgesics: case-cohort study.
    Park TW; Saitz R; Ganoczy D; Ilgen MA; Bohnert AS
    BMJ; 2015 Jun; 350():h2698. PubMed ID: 26063215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discontinuation and tapering of prescribed opioids and risk of overdose among people on long-term opioid therapy for pain with and without opioid use disorder in British Columbia, Canada: A retrospective cohort study.
    Kennedy MC; Crabtree A; Nolan S; Mok WY; Cui Z; Chong M; Slaunwhite A; Ti L
    PLoS Med; 2022 Dec; 19(12):e1004123. PubMed ID: 36454732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exposure-Response Association Between Concurrent Opioid and Benzodiazepine Use and Risk of Opioid-Related Overdose in Medicare Part D Beneficiaries.
    Hernandez I; He M; Brooks MM; Zhang Y
    JAMA Netw Open; 2018 Jun; 1(2):e180919. PubMed ID: 30646080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-fatal opioid overdose, naloxone access, and naloxone training among people who recently used opioids or received opioid agonist treatment in Australia: The ETHOS Engage study.
    Conway A; Valerio H; Peacock A; Degenhardt L; Hayllar J; Harrod ME; Henderson C; Read P; Gilliver R; Christmass M; Dunlop A; Montebello M; Whitton G; Reid D; Lam T; Alavi M; Silk D; Marshall AD; Treloar C; Dore GJ; Grebely J;
    Int J Drug Policy; 2021 Oct; 96():103421. PubMed ID: 34452808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trends in opioid use disorder and overdose among opioid-naive individuals receiving an opioid prescription in Massachusetts from 2011 to 2014.
    Burke LG; Zhou X; Boyle KL; Orav EJ; Bernson D; Hood ME; Land T; Bharel M; Frakt AB
    Addiction; 2020 Mar; 115(3):493-504. PubMed ID: 31691390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prescription drugs with potential for misuse in Irish prisons: analysis of national prison prescribing trends, by gender and history of opioid use disorder, 2012 to 2020.
    Durand L; Keenan E; O'Reilly D; Bennett K; O'Hara A; Cousins G
    BMC Psychiatry; 2023 Oct; 23(1):725. PubMed ID: 37803285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of Benzodiazepine Treatment for Sleep Disorders With Drug Overdose Risk Among Young People.
    Bushnell GA; Gerhard T; Keyes K; Hasin D; Cerdá M; Olfson M
    JAMA Netw Open; 2022 Nov; 5(11):e2243215. PubMed ID: 36413369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of Overdose with Exposure to Prescription Opioids, Benzodiazepines, and Non-benzodiazepine Sedative-Hypnotics in Adults: a Retrospective Cohort Study.
    Cho J; Spence MM; Niu F; Hui RL; Gray P; Steinberg S
    J Gen Intern Med; 2020 Mar; 35(3):696-703. PubMed ID: 31919729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Receipt of Opioid Agonist Treatment in provincial correctional facilities in British Columbia is associated with a reduced hazard of nonfatal overdose in the month following release.
    McLeod KE; Buxton JA; Karim ME; Martin RE; Nosyk B; Kurz M; Scow M; Felicella G; Slaunwhite AK
    PLoS One; 2024; 19(7):e0306075. PubMed ID: 38985687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.